Synthesis of Vixotrigine, a Voltage- and Use-Dependent Sodium Channel Blocker. Part 2: Development of a Late-Stage Process
暂无分享,去创建一个
D. Patience | Frederick Osei-Yeboah | D. G. Walker | M. Nonnenmacher | S. Opalka | Tamera L. Mack | E. Irdam | J. Guzowski | D. Kwok | Erin M. O’Brien | Markus J. Stöckli | M. Grohmann | W. Kiesman | S. Sahli | P. Cerea | Robbie Chen | Wenli Liang | Vincent Couming | Chaozhan Gu | Xin Zhang | Thiemo Stucki | H. Matzinger | R. Kuhn | M. Thut | B. Haefner | J. Lotz
[1] Gerard M P Giblin,et al. Synthesis of Vixotrigine, a Use-Dependent Sodium Channel Blocker. Part 1: Development of Bulk Supply Routes to Enable Proof of Concept , 2020 .
[2] M. Hosoya,et al. Investigation into an Unexpected Impurity: A Practical Approach to Process Development for the Addition of Grignard Reagents to Aldehydes Using Continuous Flow Synthesis , 2020 .
[3] M. Baumann,et al. A Perspective on Continuous Flow Chemistry in the Pharmaceutical Industry , 2020, Organic Process Research & Development.
[4] M. Obermann. Recent advances in understanding/managing trigeminal neuralgia , 2019, F1000Research.
[5] D. T. McQuade,et al. A Holistic Approach to Streamlining Pharmaceutical Processes: A Conversation , 2019, Organic process research & development.
[6] H. Görls,et al. Direct Synthesis of Heavy Grignard Reagents: Challenges, Limitations, and Derivatization. , 2018, Chemistry.
[7] Timothy M. Braden,et al. The Evolving State of Continuous Processing in Pharmaceutical API Manufacturing: A Survey of Pharmaceutical Companies and Contract Manufacturing Organizations , 2018 .
[8] John D. Hayler,et al. Inspiring process innovation via an improved green manufacturing metric: iGAL , 2018 .
[9] D. Hughes,et al. Applications of Flow Chemistry in Drug Development: Highlights of Recent Patent Literature , 2018 .
[10] T. Hirao,et al. Quinonediimines as redox-active organocatalysts for oxidative coupling of aryl- and alkenylmagnesium compounds under molecular oxygen. , 2016, Chemical communications.
[11] Martin D. Johnson,et al. Operation Strategy Development for Grignard Reaction in a Continuous Stirred Tank Reactor , 2016 .
[12] M. Obermann,et al. Novel design for a phase IIa placebo-controlled, double-blind randomized withdrawal study to evaluate the safety and efficacy of CNV1014802 in patients with trigeminal neuralgia , 2013, Trials.
[13] Steven V Ley,et al. Flow chemistry syntheses of natural products. , 2013, Chemical Society reviews.
[14] Antonio Ramirez,et al. A mechanistic study on the amidation of esters mediated by sodium formamide. , 2012, The Journal of organic chemistry.
[15] Daniele Vigo,et al. Reaction of Grignard reagents with carbonyl compounds under continuous flow conditions , 2010 .
[16] G. Rummel,et al. Discovery of 3-(1H-indol-3-yl)-4-[2-(4-methylpiperazin-1-yl)quinazolin-4-yl]pyrrole-2,5-dione (AEB071), a potent and selective inhibitor of protein kinase C isotypes. , 2009, Journal of medicinal chemistry.
[17] H. Weinmann,et al. Activation of Mg Metal for Safe Formation of Grignard Reagents on Plant Scale , 2002 .
[18] Y. Kumazawa,et al. Synthesis of 7-Methyl-3-β-D-ribofuranosylwye, the Putative Structure for the Hypermodified Nucleoside Isolated from Archaebacterial Transfer Ribonucleic Acids , 1990 .